mitoxantrone hydrochloride - Medications

Browse 3 medications containing mitoxantrone hydrochloride. Open a product record to review formulation details, related brands, manufacturers, and label-backed information.

Mitoxantrone MITOXANTRONE
HOSPIRA, INC. FDA Rx Only

Mitoxantrone Injection, USP (concentrate) is a synthetic antineoplastic anthracenedione for intravenous use. The molecular formula is C 22 H 28 N 4 O 6 ∙2HCl and the molecular weight is 517.41. It is supplied as a concentrate that MUST BE DILUTED PRIOR TO INJECTION. The concentrate is a sterile, nonpyrogenic, dark blue aqueous solution containing mitoxantrone hydrochloride equivalent to 2 mg/mL mitoxantrone free base, with sodium chloride (0.80% w/v), sodium metabisulfite (0.01% w/v), sodium acetate (0.005% w/v), acetic acid (0.046% w/v), and Water for Injection, USP as inactive ingredients. The solution has a pH of 3.0 to 4.5 and contains 0.14 mEq of sodium per mL. The product does not contain preservatives. The chemical name is 1, 4-dihydroxy-5, 8-bis[[2-[(2-hydroxyethyl) amino]ethyl]amino]-9,10- anthracenedione dihydrochloride and the structural formula is: Chemical Structure

Mitoxantrone MITOXANTRONE HYDROCHLORIDE
FRESENIUS KABI USA, LLC FDA Rx Only

Mitoxantrone Injection, USP (concentrate) is a synthetic antineoplastic anthracenedione for intravenous use. It is supplied as a concentrate that MUST BE DILUTED PRIOR TO INJECTION. The concentrate is a sterile, nonpyrogenic, dark blue aqueous solution containing mitoxantrone hydrochloride equivalent to 2 mg/mL mitoxantrone free base, with the following inactive ingredients: sodium chloride (0.800% w/v), sodium acetate (0.005% w/v), acetic acid (0.046% w/v), and water for injection. The solution has a pH of 3.0 to 4.5 and contains 0.14 mEq of sodium per mL. The product does not contain preservatives. The chemical name is 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl) amino]ethyl]amino]-9,10- anthracenedione dihydrochloride and the structural formula is: structure

mitoXANTRONE MITOXANTRONE
MEITHEAL PHARMACEUTICALS INC. FDA Rx Only

Mitoxantrone injection, USP (concentrate) is a synthetic antineoplastic anthracenedione for intravenous use. It is supplied as a concentrate that MUST BE DILUTED PRIOR TO INJECTION. The concentrate is a sterile, nonpyrogenic, dark blue aqueous solution containing mitoxantrone hydrochloride, USP equivalent to 2 mg per mL mitoxantrone free base, with sodium chloride (0.80% w/v), sodium acetate anhydrous (0.005% w/v), glacial acetic acid (0.046% w/v) and water for injection as inactive ingredients. The solution has a pH of 3 to 4.5 and contains 0.14 mEq of sodium per mL. The product does not contain preservatives. The chemical name is 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl) amino]ethyl]amino]-9,10-anthracenedione dihydrochloride and the structural formula is: C 22 H 28 N 4 O 6 •2HCl M.W. 517.41 structure

About mitoxantrone hydrochloride

This collection groups medications in our database that include mitoxantrone hydrochloride. It currently includes 3 matching listings. Open a result to review formulation details, related brands, manufacturers, and product labels.

What You Can Review

Use this page to find products that share the same indexed ingredient name, then open drug detail pages for dosage, labeling, and related navigation.

Safety Information

Always consult with a qualified healthcare provider before starting, stopping, or changing any medication. The information provided on this page is for educational purposes only and does not constitute medical advice.

Medical Tools & Resources

← Back to search